Kai Breuhahn

9PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 24, 2026
A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

|Mar 12, 2024
SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma.

Shan Wan, Quan-Yao He, Yun Yang

|Mar 04, 2024
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication.

Kaijing Liu, Lilija Wehling, Shan Wan

|Nov 02, 2023
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.

Anna-Lena Scherr, Luisa Nader, Kaiyu Xu

|Oct 18, 2022
Spatial modeling reveals nuclear phosphorylation and subcellular shuttling of YAP upon drug-induced liver injury.

Lilija Wehling, Liam Keegan, Paula Fernández-Palanca

|Nov 24, 2021
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.

Darko Castven, Carolin Czauderna, Diana Becker

Pageof 2

Frequent Collaborators

1 joint publications

Jens Marquardt

1 joint publications

Stefan Thomann

1 joint publications

Lilija Wehling

1 joint publications

Reham Hassan